Results 31 to 40 of about 66,511 (307)

Immediate access arteriovenous grafts versus tunnelled central venous catheters: study protocol for a randomised controlled trial [PDF]

open access: yes, 2015
Background Autologous arteriovenous fistulae (AVF) are the optimal form of vascular access for haemodialysis. AVFs typically require 6 to 8 weeks to “mature” from the time of surgery before they can be cannulated.
Aitken, Emma   +6 more
core   +2 more sources

Thrombolytic therapy for central venous catheter occlusion

open access: yesHaematologica, 2012
Background Long-term central venous catheters have improved the quality of care for patients with chronic illnesses, but are complicated by obstructions which can result in delay of treatment or catheter removal.Design and Methods This paper reviews ...
Jacquelyn L. Baskin   +6 more
doaj   +1 more source

Stratification of THROMBOTIC RISK in patients that are undergoing to PICC implantation. The “CoRa-MaPiCC STUDY” [PDF]

open access: yes, 2018
Background: The PICC is a central venous system inserted in the peripherally vein. The central peripheral catheter catheter system (PICC=peripherally inserted central catheters) is a widely used procedure in clinical practice by medical and nurse team ...
Giacopelli, Pietro   +5 more
core   +1 more source

Exploring attitudes towards a randomised controlled trial of venous access devices – a nested pre-trial qualitative study [PDF]

open access: yes, 2015
Purpose: This pre-trial qualitative research study was carried out to explore patient and clinical staff attitudes to central venous access devices (CVADs). In addition, views about participation in a randomised controlled trial (RCT) were explored with
Kelly, Linda   +4 more
core   +1 more source

HIGH RISK NEWBORNS USING PERIPHERAL VENOUS CATHETERS

open access: yesCogitare Enfermagem, 2015
This observational, prospective study aimed to describe the profile of newborns that use peripheral venous catheters and present risk factors for the development of complications.
Mitzy Tannia Reichembach Danski   +4 more
doaj   +1 more source

A central line care maintenance bundle for the prevention of central line–associated bloodstream infection in non–intensive care unit settings [PDF]

open access: yes, 2016
OBJECTIVE: To evaluate a central line care maintenance bundle to reduce central line-associated bloodstream infection (CLABSI) in non-ICU settings. DESIGN: Before-after trial with 12 month follow-up period.
Ball, Kelly   +7 more
core   +2 more sources

Securing All intraVenous devices Effectively in hospitalised patients—the SAVE trial: study protocol for a multicentre randomised controlled trial [PDF]

open access: yes, 2015
Introduction: Over 70% of all hospital admissions have a peripheral intravenous device (PIV) inserted; however, the failure rate of PIVs is unacceptably high, with up to 69% of these devices failing before treatment is complete.
Aukerman   +35 more
core   +3 more sources

Adaptive 4D‐Printed Vascular Stents With Low‐Temperature‐Activated and Intelligent Deployment

open access: yesAdvanced Functional Materials, EarlyView.
Microarchitected coronary artery stents were fabricated using a polycaprolactone (PCL)‐based shape memory polymer (SMP) composite via projection micro‐stereolithography (PµSL) 4D printing. By incorporating diethyl phthalate (DEP) as a plasticizer, the thermal transition temperature (Ttran) was modulated to about 37°C, enabling rapid and autonomous ...
Yannan Li   +12 more
wiley   +1 more source

How to insert a PICC: practical tips for the intensive care physician

open access: yesAboutOpen, 2021
Peripherally inserted central catheters (PICCs) are central vascular access devices inserted via deep veins of the arm, also useful in critical care settings.
Stefano Elli   +2 more
doaj   +1 more source

Drug‐Free Thrombolysis Mediated by Physically Activated Micro/Nanoparticles

open access: yesAdvanced Functional Materials, EarlyView.
Overview of particle‐mediated thrombolytic effects (thermal, mechanical, and chemical) and their activating physical stimuli (light, ultrasound, and magnetic field) in drug‐free thrombolysis. ABSTRACT Thrombus‐associated disorders rank among the world's leading causes of death, with ischemic heart disease and stroke as the main contributors.
Pierre Sarfati   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy